4th Quarter - Report

ML STRATEGIES, LLC for ASTELLAS PHARMA US, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues relating to the implementation of the Affordable Health Care Act; H. R. 2182, the Generating Antibiotic Incentives Now (GAIN) Act; S.99, American Medical Isotope Production Act; Issues pertaining to cancer research and treatment; Issues pertaining to drug safety; Issues pertaining to the reauthorization of the Prescripton Drug User Free Act (PDUFA); Issues pertaining to the development of new antibiotics.

Foreign entity interest: Astellas Phara, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

LobbyistCovered position, as disclosed
KEVIN MICHAEL KAPPEL —
JEREMY RABINOVITZ —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 99 (112th), H.R. 2182 (112th)

Medicare/Medicaid MMM

General issues pertaining to funding levels for Medicare and Medicaid.

Foreign entity interest: Astellas Phara, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

LobbyistCovered position, as disclosed
KEVIN MICHAEL KAPPEL —
JEREMY RABINOVITZ —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.